business news in context, analysis with attitude

The Financial Times has a story about gene editing (GE), described as “the biggest technical advance in bioscience since the discovery of ‘recombinant DNA’ technology - artificially mixing genetic material - in 1973.” It isn’t the same as genetic modification, but researchers are concerned that regulators will equate the two, which could slow down the advances that they feel GE can provide.

An excerpt:

“Proponents of gene editing hope it can avoid the criticism and regulatory scrutiny that slowed the introduction of GM, because it usually alters existing genes rather than adding foreign DNA to the plant. In the US and Canada, the initial response of authorities has been that gene-edited crops will not fall under the regulatory regime of genetically modified organisms (GMOs) but the EU is taking a different view.”

You can read the entire story here.
KC's View: